Endpoints News

Lilly, Boehringer retrench in Germany on proposed health spending cuts
因拟议削减医疗支出,礼来与勃林格殷格翰在德国收缩业务

Backlash is brewing against a sweeping overhaul of Germany’s health insurance system as Eli Lilly and Boehringer Ingelheim slash investment in the country.
随着礼来和勃林格殷格翰削减在德投资,德国医疗保险体系的一项全面改革正酿起强烈反弹。

本报道最初发表于Endpoints News。请点击这里查看原文

Backlash is brewing against a sweeping overhaul of Germany’s health insurance system as Eli Lilly and Boehringer Ingelheim slash investment in the country.

在德国针对其医疗保险体系的大规模改革酝酿强烈反弹之际,礼来(Eli Lilly)和勃林格殷格翰(Boehringer Ingelheim)正大幅削减在德国的投资。

您已阅读5%(268字),剩余95%(5217字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归Endpoints News所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×